PHARMACEUTICAL AND PHARMACOLOGICAL ASPECTS OF CREATING A NEW COMBINATION DRUG WITH ANTIVIRAL ACTIVITY

2025

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.63294/afucon/vol11iss1/280
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

This article describes the pharmaceutical aspects of creating a combination drug: pharmaceutical compatibility of active and inactive ingredients, selection of dosage form, its composition and production technology, quality control, standardization, validation of developed methods, and stability during storage. Experimental studies of the specific activity of the combination drug in vitro are presented.